logo
'Old people smell' is real, experts say — here's how to avoid it as you age

'Old people smell' is real, experts say — here's how to avoid it as you age

Fox News5 hours ago
Many people have posted on social media about the so-called "old people smell," described as a faintly musty or greasy scent sometimes associated with older adults.
This phenomenon is more science than stigma, experts say.
"I think we all know this smell," Dr. Dan Wesson, professor at the University of Florida College of Medicine, told Fox News Digital.
"Some describe it as dusty, like an old book. Others as oily or greasy. None of these, of course, are flattering descriptions, and that's why this isn't the kind of smell you want to label a person with," he noted.
The skin is the largest organ in the body, so it makes sense that it will undergo significant changes as the body ages, according to Wesson.
For most of our lives, body odor stems from sweat, bacteria and dead skin, which can be addressed with basic hygiene. But with aging, changes in skin composition and oil production make smells more complex, the expert noted.
"Skin cells accumulate damage over time," he said — and those damaged cells can release compounds that contribute to odor.
A key culprit is 2-nonenal, a compound that emerges from lipid oxidation, which is the process of fats in the cells breaking down due to imbalances in the body, studies show.
This compound is unique to aging skin and has a greasy, cardboard-like odor.
2-nonenal is not easily washed off with regular hygiene practices, "by nature of its fatty composition," Wesson said.
"This is why managing this body odor requires more complex solutions," he said.
Wesson suggests taking a more holistic approach by eating antioxidant-rich foods like fruits and vegetables, staying hydrated and using antioxidant skincare.
Some medications — including those for high cholesterol, ADHD or depression — could also impact the body's metabolism and how much it sweats, contributing to odor, according to Wesson.
Hormones can also influence how people smell. Post-menopausal women often experience changes in skin and scent due to declining estrogen levels, studies show.
"Hormone replacement therapy can ward off some changes that may alter body odor – though [HRT] is not without risks and should be discussed carefully with your doctor," Wesson said.
Not all odor changes are normal, experts warn.
"A sudden change in body odor can be a warning sign of an underlying health issue," Wesson warned.
Diseases like cancer and dementia, for example, can alter body chemistry and scent.
"If your loved ones report a sudden change, you should consult your doctor," Wesson advised.
Some people may worry about how they smell even when others wouldn't notice. That concern could stem from parosmia, a distorted sense of smell, or olfactory hallucinations, where unpleasant smells are imagined.
"People can perceive odors that aren't there at all," Wesson said. "It's important to consider whether it's a real odor or just a change in perception."
For more Health articles, visit www.foxnews.com/health
By understanding the biology behind age-related odor and taking a proactive approach to health and skincare, this condition can be managed, experts say.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Alfa Cytology Announces Holistic Approach to RDC Development Services Supported by In Vivo Studies in Radiopharmaceuticals
Alfa Cytology Announces Holistic Approach to RDC Development Services Supported by In Vivo Studies in Radiopharmaceuticals

Associated Press

time16 minutes ago

  • Associated Press

Alfa Cytology Announces Holistic Approach to RDC Development Services Supported by In Vivo Studies in Radiopharmaceuticals

Illustration of TAT Alfa Cytology has announced RDC development services supported by In Vivo studies in radiopharmaceuticals. Alfa Cytology, a leading-edge biotech company engaged in cancer research, has released its services on robust RDC (Radionuclide Drug Conjugate) development technical support for radiopharmaceuticals. The services are specifically designed to transform the radiopharmaceutical industry, enhancing quality and precision for disease diagnosis and therapy. The oncology and diagnostic imaging fields are rapidly expanding, with an increasing need for transformative approaches to medical research and treatment. As current methods in disease diagnosis and treatment often lack the specificity, sensitivity, and customization demanded by the cutting edge of diagnostic medicine and theranostics, Alfa Cytology has developed the platform to meet the individualized needs of its clients. This takes a highly individualized approach, accounting for the specific biochemical and kinetic characteristics of the large variety of radiotracers and therapeutics in use. Alfa Cytology's expert services can be leveraged for the custom synthesis, optimization, and quality control of radiopharmaceuticals, to a standard of safety and efficacy unequaled by other service providers. An essential component is in vivo studies in radiopharmaceuticals. These studies, which give critical insights into the in vivo interactions and pharmacodynamics of radiopharmaceuticals, form the backbone of a rigorous approach to therapeutic radiopharmaceutical development. The research is supported by an extensive imaging and analytical infrastructure, enabling researchers to better understand the biodistribution, safety, pharmacokinetics, and overall therapeutic potential of next-generation radiopharmaceutical agents. The in vivo research option is a critical tool in efforts to develop more targeted and individualized radiopharmaceutical therapeutics and diagnostics. Alfa Cytology offers a wide range of technical support options and expert services for research teams, including custom synthesis of radiotracers, radionuclide production, labeling methodologies, and advanced analytical support to maximize radiochemical purity, as well as radioanalytical support and method development. Alfa Cytology continues to expand its service offerings and is continuously updating its highly experienced technical teams to meet the increasingly complex demands of the research community and to continue to be a resource for innovation and development in diagnostic imaging and cancer therapy. Alfa Cytology provides a fully integrated infrastructure to leverage RDC services and take advantage of cutting-edge in vivo research, connecting the laboratory to the real world. About Alfa Cytology Alfa Cytology, headquartered in New York, is a CRO company, offering state of the art solutions in radiopharmaceutical R&D. Alfa Cytology's team of industry veterans have assembled a set of broad integrated skills in molecular imaging, radiochemistry, and regulatory sciences, which allow them to provide next-generation services across the broad range of research needs within the community. For more information on the newest tools and solutions in radiopharmaceuticals, visit our service pages to learn how Alfa Cytology is redefining the future of cancer research and nuclear medicine. Media Contact Company Name: Alfa Cytology Contact Person: Thassia C. Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Alfa Cytology Announces Holistic Approach to RDC Development Services Supported by In Vivo Studies in Radiopharmaceuticals

Axolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis
Axolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis

Associated Press

time16 minutes ago

  • Associated Press

Axolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis

47-Ingredient Formula Targets Workplace Stress and Mental Fatigue in High-Performance Workers Axoltannounced the launch of its revolutionary brain health supplement designed specifically for high-performing professionals experiencing mental fatigue, focus issues, and cognitive decline. Research reveals that psychological distress now affects 50% of working professionals globally¹, with studies demonstrating measurable cognitive impairment during high-stress periods². For ambitious professionals, these statistics reflect a fundamental threat to sustained mental performance. 'Our modern brain is chronically overloaded and undernourished,'said Martin Valovsky, Axolt founder.'We created Axolt because most cognitive supplements offer temporary stimulation when high performers need comprehensive brain nutrition that supports stress response and peak cognitive function.' A Different Approach Unlike conventional nootropics that rely on caffeine and synthetic stimulants, Axolt delivers a blend of47 science-backed ingredientstargeting cognitive resilience and sustained mental performance. The formula combines stress-supporting adaptogens, neuroprotective polyphenols, and brain-supporting nutrients to support focus, memory, and mental energy without crashes. 'Mental clarity and focus aren't optional, they're the difference between winning and losing,'said Andrew Bustamante, former CIA intelligence officer and Axolt user.'That's why I drink Axolt daily.' Availability Available as a berry-flavored daily supplement for professionals facing high cognitive demands onthe Axoltwebsite. *The statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Sources: ¹ Centre for Mental Health. COVID-19 and the Nation's Mental Health: A Review of the Evidence Published So Far. 2024. ² PMC study on work-related stress and cognitive functioning during COVID-19. To request interviews, samples, or expert commentary, contact:[email protected]

AI-Assisted Technique Can Measure and Track Aging Cells
AI-Assisted Technique Can Measure and Track Aging Cells

Associated Press

time16 minutes ago

  • Associated Press

AI-Assisted Technique Can Measure and Track Aging Cells

NEW YORK, July 7, 2025 /PRNewswire/ -- A combination of high-resolution imaging and machine learning, also known as artificial intelligence (AI), can track cells damaged from injury, aging, or disease, and that no longer grow and reproduce normally, a new study shows. These senescent cells are known to play a key role in wound repair and aging-related diseases, such as cancer and heart disease, so tracking their progress, researchers say, could lead to a better understanding of how tissues gradually lose their ability to regenerate over time or how they fuel disease. The tool could also provide insight into therapies for reversing the damage. Led by NYU Langone Health Department of Orthopedic Surgery researchers, the study included training a computer system to help analyze animal cells damaged by increasing concentrations of chemicals over time to replicate human aging. Cells continuously confronted with environmental or biological stress are known to senesce, meaning they stop reproducing and start to release telltale molecules indicating that they have suffered injury. Publishing in the journal Nature Communications online July 7, the researchers' AI analysis revealed several measurable features connected to the cell's control center (nucleus), that, when taken together, closely tracked with the degree of senescence in the tissue or group of cells. This included signs that the nucleus had expanded, had denser centers or foci, and had become less circular and more irregular in shape. Its genetic material also stained lighter than normal with standard chemical dyes. Further testing confirmed that cells with these characteristics were indeed senescent, showing signs that they had stopped reproducing, had damaged DNA, and had densely packed enzyme-storing lysosomes. The cells also demonstrated a response to existing senolytic drugs. From their analysis, researchers created what they term a nuclear morphometric pipeline (NMP) that uses the nucleus's changed physical characteristics to produce a single senescent score to describe a range of cells. For example, groups of fully senescent cells could be compared to a cluster of healthy cells on a scale from minus 20 to plus 20. To validate the NMP score, the researchers then showed that it could accurately distinguish between healthy and diseased mouse cells from young to older mice, age 3 months to more than 2 years. Older cell clusters had significantly lower NMP scores than younger cell clusters. The researchers also tested the NMP tool on five kinds of cells in mice of different ages with injured muscle tissue as it underwent repair. The NMP was found to track closely with changing levels of senescent and nonsenescent mesenchymal stem cells, muscle stem cells, endothelial cells, and immune cells in young, adult, and geriatric mice. For example, use of the NMP was able to confirm that senescent muscle stem cells were absent in control mice that were not injured, but present in large numbers in injured mice immediately after muscle injury (when they help initiate repair), with gradual loss as the tissue regenerated. Final testing showed that the NMP could successfully distinguish between healthy and senescent cartilage cells, which were 10 times more prevalent in geriatric mice with osteoarthritis than in younger, healthy mice. Osteoarthritis is known to progressively worsen with age. 'Our study demonstrates that specific nuclear morphometrics can serve as a reliable tool for identifying and tracking senescent cells, which we believe is key to future research and understanding of tissue regeneration, aging, and progressive disease,' said study senior investigator Michael Wosczyna, PhD. Wosczyna is an assistant professor in the Department of Orthopedic Surgery at the NYU Grossman School of Medicine. Wosczyna says his team's study confirms the NMP's broad application for study of senescent cells across all ages and differing tissue types, and in a variety of diseases. He says the team plans further experiments to examine use of the NMP in human tissues, as well as combining the NMP with other biomarker tools for examining senescence and its various roles in wound repair, aging, and disease. The researchers say their ultimate goal for the NMP, for which NYU has filed a patent application, is to use it to develop treatments that prevent or reverse negative effects of senescence on human health. 'Our testing platform offers a rigorous method to more easily than before study senescent cells and to test the efficacy of therapeutics, such as senolytics, in targeting these cells in different tissues and pathologies,' said Wosczyna, who plans to make the NMP freely available to other researchers. 'Existing methods to identify senescent cells are difficult to use, making them less reliable than the nuclear morphometric pipeline, or NMP, which relies on a more commonly used stain for the nucleus,' said study co-lead investigator Sahil Mapkar, BS, Mapkar is a doctoral candidate at the NYU Tandon School of Engineering. Funding for the study was provided by National Institutes of Health grant R01AG053438 and the Department of Orthopedic Surgery at NYU Langone. Besides Wosczyna and Makpar, NYU Langone researchers involved in this study are co-lead investigators Sarah Bliss, and Edgar Perez Carbajal, and study co-investigators Sean Murray, Zhiru Li, Anna Wilson, Vikrant Piprode, Youjin Lee, Thorsten Kirsch, Katerina Petroff, and Fengyuan Liu. About NYU Langone Health NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 115 comprehensive academic medical centers across the nation for three years in a row, and U.S. News & World Report recently placed nine of its clinical specialties among the top five in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. With $14.2 billion in revenue this year, the system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise. Media Contact David March 212-404-3528 [email protected] STUDY LINK STUDY DOI 10.1038/s41467-025-60975-z View original content to download multimedia: SOURCE NYU Langone Health System

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store